StreetInsider.com News Articles

Form 8-K CARLSMED, INC. For: Jun 03

Wed, 03 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260603/26598767.html

Form 8-K CARLSMED, INC. For: Jun 03

Wed, 03 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260603/26598767.html

Carlsmed, Inc. (CARL) Tops Q1 EPS by 5c

Tue, 05 May 2026 18:09:06 -0400

Carlsmed, Inc. (NASDAQ: CARL) reported Q1 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $16.1 million.

For earnings history and earnings-related data on Carlsmed, Inc. (CARL) click here.

Form 10-Q CARLSMED, INC. For: Mar 31

Tue, 05 May 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260505/26434771.html

Form 10-Q CARLSMED, INC. For: Mar 31

Tue, 05 May 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260505/26434771.html

Form 8-K CARLSMED, INC. For: May 05

Tue, 05 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260505/26434506.html

Form 8-K CARLSMED, INC. For: May 05

Tue, 05 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260505/26434506.html

Carlsmed® Reports First Quarter 2026 Financial Results

Tue, 05 May 2026 16:01:00 -0400

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year

Full year 2026 revenue guidance raised to $72 million to $77 million

CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the first quarter ended March 31, 2026.

“We began 2026 with strong momentum, delivering 58% year-over-year revenue growth, publishing meaningful clinical data, and debuting new products to continue to advance our mission of improved patient outcomes

Carlsmed® Reports First Quarter 2026 Financial Results

Tue, 05 May 2026 16:01:00 -0400

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year

Full year 2026 revenue guidance raised to $72 million to $77 million

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Tue, 28 Apr 2026 16:01:00 -0400

CARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and Chief Executive Officer, will participate in the following investor conferences.

Bank of America Global Healthcare Conference in Las Vegas, NV. Fireside chat on Tuesday, May 12, 2026, at 4:20 PM PT. A live webcast will be available to registered participants, and management will host one-on-one meetings on the same day.
Jefferies Global Healthcare Conference in New York, NY. The Company will host one-on-one meetings

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Tue, 28 Apr 2026 16:01:00 -0400

Bank of America Global Healthcare Conference in Las Vegas, NV. Fireside chat on Tuesday, May 12, 2026, at 4:20 PM PT. A live webcast will be available to registered participants, and management will host one-on-one meetings on the same day.
Jefferies Global Healthcare Conference in New York, NY. The Company will host one-on-one meetings

Form ARS CARLSMED, INC. For: Dec 31

Wed, 22 Apr 2026 08:40:00 -0400

si-local-file:///var/storage/secattach/20260422/26347996.html

Form ARS CARLSMED, INC. For: Dec 31

Wed, 22 Apr 2026 08:40:00 -0400

si-local-file:///var/storage/secattach/20260422/26347996.html

Form DEFA14A CARLSMED, INC.

Wed, 22 Apr 2026 08:35:00 -0400

si-local-file:///var/storage/secattach/20260422/26347969.html

Form DEFA14A CARLSMED, INC.

Wed, 22 Apr 2026 08:35:00 -0400

si-local-file:///var/storage/secattach/20260422/26347969.html

Form DEF 14A CARLSMED, INC. For: Jun 03

Wed, 22 Apr 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260422/26347892.html

Form DEF 14A CARLSMED, INC. For: Jun 03

Wed, 22 Apr 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260422/26347892.html

Q1 MedTech quarterly preview: BTIG